Epinephrine pre-filled syringe - Adamis Pharmaceuticals

Drug Profile

Epinephrine pre-filled syringe - Adamis Pharmaceuticals

Alternative Names: Epinephrine injection PFS - Adamis Pharmaceuticals; Epinephrine PFS - Adamis Pharmaceuticals

Latest Information Update: 23 Mar 2017

Price : $50

At a glance

  • Originator Adamis Pharmaceuticals Corporation
  • Class Antiarrhythmics; Antihaemorrhagics; Antihypotensives; Bronchodilators; Catecholamines; Ethanolamines; Small molecules
  • Mechanism of Action Adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Anaphylaxis

Most Recent Events

  • 23 Mar 2017 Adamis' Epinephrine Pre-filled Syringe is still at Preregistration stage for Anaphylaxis in USA (Parenteral, Injection)
  • 19 Jan 2017 US FDA accepts NDA for epinephrine pre-filled syringe for Anaphylaxis for review
  • 16 Dec 2016 Adamis resubmits the NDA for epinephrine pre-filled syringe for Anaphylaxis in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top